Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials Wenxin LuoZhoufeng WangWeimin Li Review – Cancer Research 17 July 2018 Pages: 1851 - 1859
An insight into the molecular genetics of a uveal melanoma patient cohort Susan KennedyMichael RiceAnnemarie Larkin Original Article – Cancer Research 14 July 2018 Pages: 1861 - 1868
Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice Jingping QiuXiaoting LiYan Xin Original Article – Cancer Research Open access 24 July 2018 Pages: 1869 - 1886
Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma Ioannis PoziosThomas KnöselHendrik Seeliger Original Article – Cancer Research 25 July 2018 Pages: 1887 - 1897
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer Sabine HeubleinKlaus FrieseAurelia Vattai Original Article–Cancer Research 30 July 2018 Pages: 1899 - 1907
PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models Yuan ZhuangSihan LiGuang Li Original Article – Cancer Research 03 August 2018 Pages: 1909 - 1920
Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer Claudia StumpfDaniel KaemmererAmelie Lupp Original Article – Cancer Research 03 August 2018 Pages: 1921 - 1932
Diverging impact of cell fate determinants Scrib and Llgl1 on adhesion and migration of hematopoietic stem cells Banaja P. DashTina M. SchnöderFlorian H. Heidel Original Article – Cancer Research 06 August 2018 Pages: 1933 - 1944
Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model Yuan QiKailin XingXianghua Wu Original Article – Cancer Research 06 August 2018 Pages: 1945 - 1957
Non-participation in breast cancer screening among previous cancer patients Line Flytkjær VirgilsenAnette Fischer PedersenPeter Vedsted Original Article – Cancer Research Open access 10 August 2018 Pages: 1959 - 1966
The clinical usefulness of optical coherence tomography during cancer interventions Labrinus van ManenJouke DijkstraJ. Sven D. Mieog Review – Clinical Oncology Open access 20 June 2018 Pages: 1967 - 1990
Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC K. J. HartrumpfS. MarquardtT. Rodt Original Article – Clinical Oncology 14 July 2018 Pages: 1991 - 1999
Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study Nitin UdarCatherine Lofton-DayJean-Yves Douillard Original Article – Clinical Oncology Open access 17 July 2018 Pages: 2001 - 2010
Endometrial cancer subtypes are associated with different patterns of recurrence Tanja IgnatovHolm EggemannAtanas Ignatov Original Article – Clinical Oncology 19 July 2018 Pages: 2011 - 2017
Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis Thomas PapathemelisDunja HassasSophia Scharl Original Article – Clinical Oncology 23 July 2018 Pages: 2019 - 2027
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study Claudia BozzaLorenzo GerratanaFabio Puglisi Original Article – Clinical Oncology 24 July 2018 Pages: 2029 - 2047
Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival Athina Kladi-SkandaliKonstantinos MavridisDiamantis C. Sideris Original Article – Clinical Oncology 27 July 2018 Pages: 2049 - 2057
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice Martin FaehlingBirgit SchwenkRobert Eckert Original Article – Clinical Oncology 30 July 2018 Pages: 2059 - 2066
Evaluation of Vav3.1 as prognostic marker in endometrial cancer Maximilian BoeschSieghart SopperAlain G. Zeimet Original Article – Clinical Oncology Open access 06 August 2018 Pages: 2067 - 2076
Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities Stanislav LazarevCamille Hardy-AbeloosMichael Buckstein Original Article – Clinical Oncology 07 August 2018 Pages: 2077 - 2083